Novartis AG Cash Flows From Used In Increase Decrease In Current Borrowings
Novartis AG (NVSEF) reported Cash Flows From Used In Increase Decrease In Current Borrowings of $5.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings · last filed 2026-02-04
- Novartis AG cash flows from used in increase decrease in current borrowings for the quarter ending 2025-06-30 was $850.00M, a 49.38% increase year-over-year.
- Novartis AG cash flows from used in increase decrease in current borrowings for the quarter ending 2024-06-30 was $569.00M.
- Novartis AG cash flows from used in increase decrease in current borrowings for the quarter ending 2023-06-30 was -$709.00M, a 148.00% decline year-over-year.
- Novartis AG cash flows from used in increase decrease in current borrowings for the quarter ending 2022-06-30 was $1.48B.
| Period end | Cash Flows From Used In Increase Decrease In Current Borrowings 3 month | Cash Flows From Used In Increase Decrease In Current Borrowings 3 month as first filed | Cash Flows From Used In Increase Decrease In Current Borrowings 6 month | Cash Flows From Used In Increase Decrease In Current Borrowings 6 month as first filed | Cash Flows From Used In Increase Decrease In Current Borrowings 12 month | Cash Flows From Used In Increase Decrease In Current Borrowings 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5.00M 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $850.00M 6-K · filed 2025-07-17 | $1.41B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $958.00M 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $569.00M 6-K · filed 2025-07-17 | $1.79B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $546.00M 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | -$709.00M 6-K · filed 2024-07-18 | -$713.00M 6-K · filed 2023-07-18 | $290.00M 6-K · filed 2024-07-18 | $309.00M 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $252.00M 20-F · filed 2025-01-31 | $295.00M 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $1.48B 6-K · filed 2023-07-18 | $1.96B 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | -$3.55B 20-F · filed 2024-01-31 | -$3.52B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | -$2.29B 6-K · filed 2022-07-19 | $8.00M 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $2.26B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | -$1.17B 6-K · filed 2021-07-21 | $2.49B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | -$1.58B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | -$793.00M 6-K · filed 2020-07-21 | -$942.00M 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $1.69B 20-F · filed 2021-01-26 | $1.68B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | -$649.00M 6-K · filed 2019-07-18 | -$738.00M 6-K · filed 2018-07-18 | $1.80B 6-K · filed 2019-07-18 | $1.80B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | -$644.00M 20-F · filed 2020-01-29 | -$755.00M 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | -$1.03B 6-K · filed 2018-07-18 | $1.27B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $1.82B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $451.00M 6-K · filed 2018-01-24 |